Russell Investments Group
LKFT

Russell Investments Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Russell Investments Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,558
Closed -$929K – 3103
2020
Q3 		$929K Sell
6,558
-7,707
-54% -$1.28M ﹤0.01% 2098
2020
Q2 		$2.8M Sell
14,265
-607
-4% -$126K 0.01% 1441
2020
Q1 		$2.83M Hold
14,872
– – 0.01% 1281
2019
Q4 		$3.1M Buy
+14,872
New +$2.75M 0.01% 1479

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Investments Group's LKFT Position: Q4 2020 in Review

Russell Investments Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2020, closing a stake of 6,558 shares — an estimated $929K sold.

Russell Investments Group first reported a position in LKFT in Q4 2019 and held it in 4 quarters. The position peaked at $3.1M in Q4 2019. 116 funds tracked by Wall St. Rank hold LKFT as of Q4 2020.

  • Russell Investments Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Russell Investments Group sold 6,558 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2020, an estimated $929K.
  • Russell Investments Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2019 and held it in 4 quarters.
  • Russell Investments Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $3.1M in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2020.

Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.